When was Proxim Diagnostics founded?

Proxim Diagnostics was founded in 2010 and raised its 1st funding round within a year of its incorporation.

Where is Proxim Diagnostics located?

Proxim Diagnostics is headquartered in Sunnyvale, United States.

How many employees does Proxim Diagnostics have?

As of Apr 30, 2026, the latest employee count at Proxim Diagnostics is 10.

Is Proxim Diagnostics a funded company?

Proxim Diagnostics is a funded company, having raised a total of $22.9M across 5 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Nov 10, 2010.

When was the latest funding round of Proxim Diagnostics?

Proxim Diagnostics' latest funding was a $***** Series B round on Mar 21, 2023, with participation from 1 investor. Its primary sector is Cardiac and Vascular Disorders. In United States, the Cardiac and Vascular Disorders sector has seen $852M in funding in 2026 to date.

Where does Proxim Diagnostics rank among its competitors?

Proxim Diagnostics ranks 16th amongst 218 active competitors, of which 46 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Lumos Diagnostics, which secured $20M in Mar, 2026.

Who are the top competitors of Proxim Diagnostics?

Proxim Diagnostics' top competitors include Molbio Diagnostics, Exagen and Lumos Diagnostics. Among them, Lumos Diagnostics secured the most recent funding round in March, 2026.

Proxim Diagnostics - 2026 Company Profile, Team, Funding & Competitors

Proxim Diagnostics is a series B company based in Sunnyvale (United States), founded in 2010 by Vikram Joshi and Mikhail Briman. It operates as a Developer of a handheld immunodiagnostic device for cardiac vascular diseases. Proxim Diagnostics has raised $22.9M in funding from BioMerieux. The company has 218 active competitors, including 46 funded and 35 that have exited. Its top competitors include companies like Molbio Diagnostics, Exagen and Lumos Diagnostics.

Company Details

Developer of a handheld immunodiagnostic device for cardiac vascular diseases. The device allows detection of cardiac markers, blood gases testing, electrolytes and metabolites, infectious disease antigens and antibodies.

Website: www.proximdx.com/
Email ID: *****@proximdx.com

Key Metrics

Founded Year

2010

Location

Sunnyvale, United States

Stage

Series B

Total Funding

$22.9M in 5 rounds

Latest Funding Round

Series B, Mar 21, 2023, $*****

Investors

BioMerieux & 2 more

Ranked

16^th among 218 active competitors

Employee Count

10 as on Apr 30, 2026

Similar Companies

Molbio Diagnostics & 233 more

View Proxim Diagnostics' full profile

Proxim Diagnostics is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Proxim Diagnostics Corporation CIN: - , Belgium, Active		-	-	-

Proxim Diagnostics has raised a total funding of $22.9M over 5 rounds. Its first funding round was on Nov 10, 2010. Its latest funding round was a Series B round on Mar 21, 2023 for $*****. 1 investor participated in its latest round. Proxim Diagnostics has 3 institutional investors.

Here is the list of recent funding rounds of Proxim Diagnostics:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 21, 2023	7663714	Series B	7140596	6329274	5791559	8795722
Nov 29, 2022	8100944	Series B	3756068	5103706	6191482	5699819
Sep 17, 2018	2533899	Series A	8280466	6493567	9598453	4584443

Access funding benchmarks and valuations. Sign up today!

View details of Proxim Diagnostics's funding rounds and investors

The founders of Proxim Diagnostics are Vikram Joshi and Mikhail Briman.

Here are the details of Proxim Diagnostics' key team members:

Vikram Joshi: Co-Founder of Proxim Diagnostics.
Contact Info: 1 email address
Mikhail Briman: Co-Founder & CTO of Proxim Diagnostics.
Contact Info: 1 email address

View details of Proxim Diagnostics's Founder profiles and Board Members

Proxim Diagnostics' employee count trend

Proxim Diagnostics has 10 employees as of Apr 26. Here is Proxim Diagnostics's employee count trend over the years:

Employee count trend for Proxim Diagnostics

Uncover Proxim Diagnostics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Proxim Diagnostics include Molbio Diagnostics, Exagen and Lumos Diagnostics. Here is the list of Top 10 competitors of Proxim Diagnostics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Molbio Diagnostics 2000, Salcete (India), Series C	Developer of point-of-care molecular diagnostic platform for infectious disease detection	$124M	Motilal Oswal, Temasek & 36 others	71/100
2nd	Exagen 2002, Vista (United States), Public	Developer of diagnosis, prognosis and monitoring solutions for autoimmune connective diseases	$110M	HIG BioHealth Partners, Tullis Health Investors ... & 10 others	65/100
3rd	Lumos Diagnostics 2017, Carlsbad (United States), Public	Provider of rapid point-of-care diagnostic test solutions	$40M	Perennial, Ellerston Capital & 2 others	58/100
4th	Oncimmune 2006, Nottingham (United Kingdom), Acquired	Immunodiagnostics company developing biomarker platforms for cancer and immune diseases	-	Balderton Capital, IPF Partners & 9 others	58/100
5th	GEN inCode 2018, Manchester (United Kingdom), Public	Developer of precison medicines by combining genetic and clinical data for cardiac disease monitoring	$5.46M	Downing, Maven Capital Partners & 4 others	57/100
6th	SD Biosensor 2001, Suwon-si (South Korea), Public	Provider of point-of-care diagnostics for multiple diseases	-	Bill & Melinda Gates Foundation, Atinum Investment ... & 3 others	56/100
7th	Boston Heart Diagnostics 2007, Framingham (United States), Acquired	Developer of diagnosis for personalized care for cardiovascular diseases	$10.3M	Bain Capital Ventures, Silversmith Capital Partners ... & 8 others	51/100
8th	SmartHealth 1979, Irvine (United States), Series B	Developer precision diagnostics for vascular, metabolic, and oncological diseases	$17.3M	-	49/100
9th	Realview Imaging 2008, Yokneam Illit (Israel), Series C	Provides 3D holographic display based solutions for medical imaging applications	$25M	OurCrowd, ADIP & 10 others	49/100
10th	Myocardial Solutions 2002, Morrisonville (United States), Series B	Provider of MRI-based diagnostic software for cardiac disease	$33.9M	Pond Capital	49/100
16th	Proxim Diagnostics 2010, Sunnyvale (United States), Series B	Developer of a handheld immunodiagnostic device for cardiac vascular diseases	$22.9M	BioMerieux, UCLA Ventures & 1 others	46/100